Lindsey O. Webster - Concepedia

Concepedia

Author

Lindsey O. Webster

Research Triangle Park Foundation

Also Known As

Lindsey O. Webster, Lindsey Webster, Polli, Joseph W.

17

Publications

2.1K

Citations

12

H-Index

28

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Pharmaceutical Product Development (United States)University of North Carolina at Chapel Hill

LO

About

Lindsey O. Webster is an author at Research Triangle Park Foundation specializing in pharmacology, medicine, and pharmacodynamic modeling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	87
2	Health Sciences	1	1	42
3	Allergy	1	1	28
4	Biochemistry	1	1	42
5	Clinical Immunology	1	1	28

Lindsey O. Webster

×

12

Publications

2.1K

Citations

12

H-Index

	Year	Citations
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery Joseph W. Polli, Stephen A. Wring, Joan E. Humphreys, Journal of Pharmacology and Experimental Therapeutics	2001	658
Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs Kelly M. Mahar Doan, Joan E. Humphreys, Lindsey O. Webster, Journal of Pharmacology and Experimental Therapeutics	2002	623
IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES Jarkko Rautio, Joan E. Humphreys, Lindsey O. Webster, Drug Metabolism and Disposition	2006	259
In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor Melinda J. Reese, Paul Savina, Grant T. Generaux, Drug Metabolism and Disposition	2012	243
MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1 Maciej J. Zamek‐Gliszczynski, Keith Hoffmaster, Xianbin Tian, Drug Metabolism and Disposition	2005	73
Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from<i>in vitro</i>studies and a clinical investigation with midazolam Melinda J. Reese, Gary D. Bowers, Joan E. Humphreys, Xenobiotica	2015	48
Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport Kristina Wolf, Sapana Vora, Lindsey O. Webster, Toxicology in Vitro Bile Acid TransportHepatologyBiochemistryBiliary TractMedicine	2009	42
RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079) Jon Collins, Lori S. Jones, Michele Snyder, Neurology Clinical ImmunologyHealthy SubjectsIntravenous AdministrationImmunologyPharmacotherapy	2019	28
THE SYSTEMIC EXPOSURE OF AN N-METHYL-d-ASPARTATE RECEPTOR ANTAGONIST IS LIMITED IN MICE BY THE P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN EFFLUX TRANSPORTERS Joseph W. Polli, Todd M. Baughman, Joan E. Humphreys, Drug Metabolism and Disposition	2004	24
Temporal kinetics and concentration–response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes Richard Graham, Lindsey O. Tyler, Wojciech Król, Journal of Biochemical and Molecular Toxicology	2006	22

Page 1